Here’s how it works. The best cable modems give you greater control over your home network but they can also save you quite a lot of money over time. In the same way that upgrading to one of the ...

The US is preparing to ban the world's most popular router over national security fears. According to a report from the Wall Street Journal, Chinese-owned TP-Link is currently under investigation ...

The company plans to launch service in the "coming quarters." "We've now rolled out Breezeline mobile, and our Canadian wireless effort is well on track to go to market over the coming quarters," ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...

The deal does not include a provision to raise the debt limit. After days of heated negotiations on Capitol Hill and eleventh-hour interference from President-elect Donald Trump and his ally Elon ...

Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...

In a statement sent to Fox News Digital, Joshua Murdock, PharmD, pharmacy editor at GoodRx, commented on the "significant number" of already-approved medications that were approved for new uses in ...

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the first prescription drug to help alleviate moderate ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release ...

The Biden administration announced Monday its final weapons and aid package to Ukraine before President-elect Trump is set to take the reins in Washington. The White House announced a $1.25 ...

The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...

BRUSSELS, Dec 23 (Reuters) - U.S. chip design software company Synopsys (SNPS.O), opens new tab is set to win conditional EU antitrust approval for its $35 billion buy of Ansys (ANSS.O), opens new ...